Gyon Technologies Capital Management, LP Reata Pharmaceuticals Inc Transaction History

Gyon Technologies Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $299,690 - $563,405	15,440 New	15,440 $388,000
Q1 2022 May 12, 2022	SELL	$24.12 - $39.6 $187,291 - $307,494	-7,765 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $77,137 - $334,211	3,012 Added 63.37%	7,765 $205,000
Q3 2021 Nov 18, 2021	BUY	$100.0 - $143.02 $475,300 - $679,774	4,753 New	4,753 $478,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $1.59 Million - $3.07 Million	-20,288 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $844,291 - $1.19 Million	8,958 Added 79.06%	20,288 $2.02 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $1.16 Million - $2.09 Million	11,330 New	11,330 $1.4 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.